ABSTRACT NUMBER: ESOC2026A82 NLRP3 INHIBITION ATTENUATES INFARCT PROGRESSION AND INFLAMMATION ACROSS OCCLUSION, REPERFUSION AND SUBACUTE PHASES IN ISCHEMIC STROKE

Maximilian Bellut, Milena Strootmann, Alexander Kollikowski, Mirko Pham, Guido Stoll, Michael Schuhmann · 2026

Read ABSTRACT NUMBER: ESOC2026A82 NLRP3 INHIBITION ATTENUATES INFARCT PROGRESSION AND INFLAMMATION ACROSS OCCLUSION, REPERFUSION AND SUBACUTE PHASES IN ISCHEMIC STROKE by Maximilian Bellut, Milena Strootmann, Alexander Kollikowski, Mirko Pham, Guido Stoll, Michael Schuhmann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146222.txt.

Description

Maximilian Bellut and five co-authors present this 2026 conference abstract on blocking inflammation after a stroke. When a clot blocks a brain artery, tissue keeps dying even after blood flow returns. A protein complex called NLRP3 drives part of that harmful swelling and cell damage.

The team used mouse models of stroke, with and without the protein active in certain white blood cells. A drug called MCC950, which blocks the complex, shrank damage and improved outcomes. It helped whether given before the stroke or hours after. The team also sampled blood from human stroke patients during clot removal. The protein was already active while the artery was still blocked, they found.

Catalog record

CREATORMaximilian Bellut, Milena Strootmann, Alexander Kollikowski, Mirko Pham, Guido Stoll, Michael Schuhmann
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13146222

Browse the full library · About the Tower of Babel